RECRUITING

Effectiveness of Motivation Skills Training (MST)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will take place at four outpatient clinics serving adults with serious mental illness. Informed consent will be obtained from N=80 individuals with a Diagnostic and Statistical Manual of Mental Illnesses (DSM)-5 diagnosis of schizophrenia or schizoaffective disorder meeting inclusion/exclusion criteria to participate in a randomized controlled trial comparing Motivation Skills Training (MST) to a Healthy Behaviors Control (HBC) group. Eligible participants will receive a baseline assessment including sociodemographic and psychosocial assessments, measures of motivation, goal attainment, and quality of life, as well as measures of executive skills, community functioning, and psychiatric symptoms severity. Both MST and HBC will be implemented as once weekly group therapies. The treatment phase is approximately 12-14 weeks. MST will focus on motivation knowledge and self-regulation skills while HBC will focus on physical health and health-related skills.

Official Title

Motivation Skills Training to Enhance Functional Outcomes for People With Schizophrenia

Quick Facts

Study Start:2024-04-15
Study Completion:2025-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05805397

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18-65
  2. 2. DSM-5 Diagnosis of Schizophrenia or Schizoaffective Disorder
  3. 3. Medically and psychiatrically stable outpatient status
  4. 4. English Fluency
  1. 1. Indications of Intellectual Disability as documented in medical history or measured by \< 70 premorbid full scale Intelligence Quotient (IQ) estimate
  2. 2. Severe substance use within the past three months determined by DSM-5 criteria
  3. 3. Neurologic condition causing brain disease
  4. 4. Mild to severe cognitive impairment associated with possible dementia measured by a Mini Mental Status Exam score below 20 in individuals ages 60 and older

Contacts and Locations

Study Contact

Alice Saperstein, PhD
CONTACT
646-774-8464
Alice.Saperstein@nyspi.columbia.edu

Principal Investigator

Alice Saperstein, PhD
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

The Bridge, Inc.
New York, New York, 10025
United States
New York State Office of Mental Health
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Alice Saperstein, PhD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-15
Study Completion Date2025-11-30

Study Record Updates

Study Start Date2024-04-15
Study Completion Date2025-11-30

Terms related to this study

Keywords Provided by Researchers

  • Mental Illness
  • Motivation Skills

Additional Relevant MeSH Terms

  • Schizophrenia
  • Schizoaffective Disorder